ArticleJournal of cancer research and clinical oncology2024

Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.

Yuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.